Royal Victorian Eye and Ear Hospital
East Melbourne, Victoria, Australia
Hospital in East Melbourne, Victoria
32 Gisborne St, East Melbourne VIC 3002
About Royal Victorian Eye and Ear Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Cochlear
5
Hoffmann-La Roche
4
JHSPH Center for Clinical Trials
2
Apellis Pharmaceuticals, Inc.
1
Bausch & Lomb Incorporated
1
Center for Eye Research Australia
1
Clearside Biomedical, Inc.
1
IVERIC bio, Inc.
1
Ionis Pharmaceuticals, Inc.
1
University of California, San Francisco
1
University of Melbourne
1
Clinical Trials at Royal Victorian Eye and Ear Hospital
During the past decade, Royal Victorian Eye and Ear Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
1999-06-01
2003-06-01
Completed
510
Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration
2008-02-01
2010-04-01
Completed
49
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-10-06
2018-01-23
Terminated
975
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
2015-06-16
2018-01-04
Completed
192
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2015-03-30
2018-02-08
Terminated
202
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2015-06-24
2018-01-31
Terminated
296
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy
2015-09-24
2018-01-17
Completed
246
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Royal Victorian Eye and Ear Hospital" #1 sponsor was "Cochlear" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials
sponsored, "JHSPH Center for Clinical Trials" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Bausch & Lomb Incorporated"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Victorian Eye and Ear Hospital"
#1 collaborator was "Royal Victoria Eye and Ear Hospital" with 4 trials as a collaborator, "National Eye Institute (NEI)" with 3 trials as a collaborator, "The Hearing Cooperative Research Centre" with 2 trials as a collaborator, "Aravind Eye Hospitals, India" with 1 trials as a collaborator and "Asociación para Evitar la Ceguera en México" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Royal Victorian Eye and Ear Hospital
According to Clinical.Site data, the most researched conditions in "Royal Victorian Eye and Ear Hospital" are
"Geographic Atrophy" (7 trials), "Macular Edema" (3 trials), "Uveitis" (3 trials), "Hearing Loss" (2 trials) and "Age Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Royal Victorian Eye and Ear Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Royal Victorian Eye and Ear Hospital
Most popular intervention types in "Royal Victorian Eye and Ear Hospital" are "Drug" (11 trials), "Device" (6 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lampalizumab" (2 trials), "No intervention" (2 trials), "ACE stimulation strategy" (1 trials), "CI632" (1 trials) and "CI632D" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Royal Victorian Eye and Ear Hospital
The vast majority of trials in "Royal Victorian Eye and Ear Hospital" are
19 trials for "All" genders.
Clinical Trials Status at Royal Victorian Eye and Ear Hospital
Currently, there are NaN active trials in "Royal Victorian Eye and Ear Hospital".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Royal Victorian Eye and Ear Hospital,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Royal Victorian Eye and Ear Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 6 trials that are defined as “Not Applicable".